MedTrace Logo

Sublingual Nicotine Tablets Compared With Swedish Snus

NCT01838460 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2013-04-24

No results posted yet for this study

Summary

To compare each subject's AUCinf, after administration of one single dose of 6 mg of Nicorette sublingual nicotine tablets ( three 2mg tablets) to that of one single 1 g dose of SS containing 16 mg nicotine.

Conditions

  • Smoking Cessation

Interventions

DRUG

sublingual nicotine tablets

6 mg = 3 tablets

OTHER

Smokeless tobacco

Swedish type moist snuff

Sponsors & Collaborators

  • Commitum AB

    collaborator INDUSTRY

  • Contract Research Organization el AB

    lead INDUSTRY

Principal Investigators

  • Erik Lunell, Md, Phd · Croel AB

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-08-31
Completion
2013-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01838460 on ClinicalTrials.gov